Mini Samples ELISA Kit for Cerebral Dopamine Neurotrophic Factor (CDNF)

ARMETL1; ARMET-like protein 1; Conserved Dopamine Neurotrophic Factor; Arginine-Rich,Mutated In Early Stage Tumors-Like 1

Specificity

This assay has high sensitivity and excellent specificity for detection of Mini Samples Cerebral Dopamine Neurotrophic Factor (CDNF).
No significant cross-reactivity or interference between Mini Samples Cerebral Dopamine Neurotrophic Factor (CDNF) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Mini Samples Cerebral Dopamine Neurotrophic Factor (CDNF) and the recovery rates were calculated by comparing the measured value to the expected amount of Mini Samples Cerebral Dopamine Neurotrophic Factor (CDNF) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 80-102 94
EDTA plasma(n=5) 80-102 91
heparin plasma(n=5) 85-95 90

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Mini Samples Cerebral Dopamine Neurotrophic Factor (CDNF) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Mini Samples Cerebral Dopamine Neurotrophic Factor (CDNF) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Mini Samples Cerebral Dopamine Neurotrophic Factor (CDNF) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 91-98% 80-92% 98-105% 94-105%
EDTA plasma(n=5) 86-104% 89-96% 94-105% 94-101%
heparin plasma(n=5) 87-101% 83-93% 81-93% 96-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×60µL Assay Diluent A 1×6mL
Detection Reagent B 1×60µL Assay Diluent B 1×6mL
TMB Substrate 1×4.5mL Stop Solution 1×3mL
Wash Buffer (30 × concentrate) 1×10mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 25µL standard or sample to each well. Incubate 1 hour at 37°C;
3. Aspirate and add 25µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 25µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 25µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 20µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Neuroinflammation Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra Pubmed: 25511018
JOURNAL OF NEUROINFLAMMATION Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra Pubmed:25511018
TURKISH JOURNAL OF MEDICAL SCIENCES THE EFFECT OF KISSPEPTIN ON SPERMATOGENESIS AND APOPTOSIS IN RATS fileID:693211
Neural Regen Res Cerebral dopamine neurotrophic factor transfection in dopamine neurons using neurotensin-polyplex nanoparticles reverses 6-hydroxydopamine-induced … 34472486
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPG458Hu01 Recombinant Cerebral Dopamine Neurotrophic Factor (CDNF) Positive Control; Immunogen; SDS-PAGE; WB.
EPG458Hu61 Eukaryotic Cerebral Dopamine Neurotrophic Factor (CDNF) Positive Control; Immunogen; SDS-PAGE; WB.
APG458Hu61 Active Cerebral Dopamine Neurotrophic Factor (CDNF) Cell culture; Activity Assays.
PAG458Hu01 Polyclonal Antibody to Cerebral Dopamine Neurotrophic Factor (CDNF) WB; IHC; ICC; IP.
PAG458Hu06 Polyclonal Antibody to Cerebral Dopamine Neurotrophic Factor (CDNF) WB; IHC; ICC; IP.
MAG458Hu22 Monoclonal Antibody to Cerebral Dopamine Neurotrophic Factor (CDNF) WB; IHC; ICC; IP.
MAG458Hu26 Monoclonal Antibody to Cerebral Dopamine Neurotrophic Factor (CDNF) WB; IHC; ICC; IP.
MAG458Hu21 Monoclonal Antibody to Cerebral Dopamine Neurotrophic Factor (CDNF) WB; IHC
SEG458Hu ELISA Kit for Cerebral Dopamine Neurotrophic Factor (CDNF) Enzyme-linked immunosorbent assay for Antigen Detection.
MEG458Hu Mini Samples ELISA Kit for Cerebral Dopamine Neurotrophic Factor (CDNF) Enzyme-linked immunosorbent assay for Antigen Detection.
LMG458Hu Multiplex Assay Kit for Cerebral Dopamine Neurotrophic Factor (CDNF) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.